Volume 272, Number 17,
Issue of April 25, 1997
pp. 11503-11509
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Post-translational Fate of a Mucin-like Leukocyte
Sialoglycoprotein (CD43) Aberrantly Expressed in a Colon Carcinoma Cell
Line
(Received for publication, November 13, 1996, and in revised form, February 18, 1997)
Dan
Baeckström
From the Department of Medical Biochemistry, University of
Göteborg, Medicinaregatan 9, S-413 90 Göteborg, Sweden
This paper describes the biosynthesis of L-CanAg,
a mucin-like glycoprotein which carries the carcinoma-associated
carbohydrate epitope sialyl-Lewis a and is secreted by the colon
adenocarcinoma cell line COLO 205. Recently, it has been shown that
L-CanAg is a novel glycoform of CD43, a surface sialoglycoprotein
normally found only on hematopoietic cells. Immunoprecipitation with
-GPEP18, a novel antiserum against the cytoplasmic domain of CD43,
detected a transmembrane form of L-CanAg carrying sialyl-Lewis a. Cell surface biotinylation experiments demonstrated the presence of transmembrane L-CanAg at the plasma membrane and that COLO 205, unlike
the leukocyte cell line HL-60, contained significant amounts of
glycosylated intracellular CD43.
Immunoprecipitation of phosphate-labeled COLO 205 cells revealed that
membrane-bound L-CanAg, like leukocyte CD43, is a phosphoprotein. Interestingly, both surface- and phosphate-labeled L-CanAg were eluted
earlier from a gel filtration column than their unlabeled counterparts,
indicating that this method could separate membrane-bound L-CanAg from
its soluble form. Immunoprecipitations of pulse-chase-labeled COLO 205 lysates fractionated by gel filtration showed that decrease in
membrane-bound L-CanAg was concomitant with an increase in the
intracellular soluble form. Together, these data indicate that
transmembrane L-CanAg is fully glycosylated and phosphorylated before
the extracellular domain is cleaved off and stored inside the cell
before exocytosis.